Ralph Howe - Concepedia

Author

Ralph Howe

AstraZeneca (United Kingdom)

Also Known As

Ralph Howe, Ralph. Howe

Publications

400

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)

About

Ralph Howe is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	282
2	Biochemistry	6	6	206
3	Natural Sciences	4	4	135
4	Public Health	1	1	10
5	Biostatistics	1	1	10

Ralph Howe

Publications

355

Citations

H-Index

Page 1

	Year	Citations
ICI D7114 a novel selective β‐adrenoceptor agonist selectively stimulates brown fat and increases whole‐body oxygen consumption Brian R. Holloway, Ralph Howe, Balbir S. Rao, British Journal of Pharmacology Cardiovascular PharmacologyBrown FatExperimental PharmacologyMolecular PharmacologyOxygen Consumption	1991	82
.beta.-Adrenergic blocking agents. III. The optical isomers of pronethalol, propranolol, and several related compounds Ralph Howe, B. Srinivasa Rao Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyOptical IsomersChemistry	1968	66
Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo Thomas P. Blackburn, George A. Foster, D. T. Greenwood, European Journal of Pharmacology OptogeneticsPharmaceutical ScienceBiochemistryMedicineExperimental Pharmacology	1978	40
.beta.-Adrenergic blocking agents. I. Pronethalol and related N-alkyl and N-aralkyl derivatives of 2-amino-1-(2-naphthyl)ethanol Ralph Howe, A. F. Crowther, J. S. Stephenson, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScoreN-aralkyl DerivativesOrganic ChemistryI. Pronethalol	1968	31
Selective .beta.3-adrenergic agonists of brown adipose tissue and thermogenesis. 2. [4-[2-[(2-Hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetamides Ralph Howe, Balbir S. Rao, Brian R. Holloway, Journal of Medicinal Chemistry	1992	30
Selective .beta.3-adrenergic agonists of brown adipose tissue and thermogenesis. 1. [4-[2-[(2-Hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetates Ralph Howe, Balbir S. Rao, Brian R. Holloway, Journal of Medicinal Chemistry	1992	25
.beta.-Adrenergic blocking agents. VII. 2-(1,4-Benzodioxanyl) and 2-chromanyl analogs of pronethalol [2-isopropylamino-1-(2-naphthyl) ethanol] Ralph Howe, Balbir S. Rao, M. S. Chodnekar Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScoreOrganic ChemistryPharmacotherapyExperimental Pharmacology	1970	21
Optical isomers of 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine (viloxazine) and related compounds Ralph Howe, Thomas Leigh, Balbir S. Rao, Journal of Medicinal Chemistry	1976	18
(2,6-dimethylphenylsulphonyl)nitromethane: A new structural type of aldose reductase inhibitor which follows biphasic kinetics and uses an allosteric binding site Walter H.J. Ward, Peter N. Cook, Donald J. Mirrlees, Biochemical Pharmacology Medicinal ChemistryAldo-keto ReductaseAldehyde DehydrogenaseBiochemistryBiphasic Kinetics	1991	17
Kinetic characteristics of zeneca ZD5522, a potent inhibitor of human and bovine lens aldose reductase Peter N. Cook, Walter H.J. Ward, J. Mark Petrash, Biochemical Pharmacology Aldo-keto ReductaseBiochemistryPotent InhibitorMedicineMechanism Of Action	1995	15

Page 1